Skip to main content
. 2012 Jun 26;107(3):429–434. doi: 10.1038/bjc.2012.274

Figure 2.

Figure 2

Relationship between pharmacokinetic parameters of trifluorothymidine (TFT; Cmax and AUCinf) and the percent change of the neutrophil count of patients treated with 30–70 mg m−2 per day of TAS-102 on day 12 in 1 course. (A) Relationship between TFT Cmax and the percent change of the neutrophil count. (B) Relationship between TFT AUCinf and the percent change of the neutrophil count. Each symbol denotes an individual value.